Q4 2024 Management View CEO Corey Fishman emphasized 2024 as a pivotal year, highlighting the FDA approval of ORLYNVAH, the first and only oral penem in the U.S. for uncomplicated urinary tract ...
Black patients from rural areas who develop infections during hospital stays are nearly twice as likely to die than white urban patients according to ...